Center for Translational Investigation in Oncology, Instituto do Cancer do Estado de Sao Paulo, Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo, São Paulo, Brazil.
Division of Cancer Epidemiology, McGill University, Montreal, Canada.
Cancer Epidemiol Biomarkers Prev. 2019 Jun;28(6):1086-1088. doi: 10.1158/1055-9965.EPI-19-0114. Epub 2019 Mar 13.
Human papillomavirus (HPV) types 6 and 11 are mainly associated with the development of genital warts and recurrent respiratory papillomatosis. We examined intratypic genetic variability of both viral types with the development of cervical cytologic abnormalities in Brazilian women.
We used PCR sequencing to characterize variants of HPVs 6 and/or 11 in cervical swabs from women in the Ludwig-McGill Cohort Study. We used a binomial generalized estimating equations (GEE) model with logit link to estimate odds ratios (OR) and 95% confidence intervals (CI) for the associations between HPV 6 and 11 variants and cytologic abnormalities.
B1 and B3 HPV6 and A2 HPV11 variants were the most common isolates identified. Compared with HPV6-negative women, the ORs among women harboring HPV6 B1 or B3 variants were 6.3 (95% CI, 2.3-17.0) and 2.3 (95% CI, 0.6-9.7) for atypical cells of undetermined significance (ASCUS)/low squamous intraepithelial lesions (LSIL), respectively, and 1.7 (95% CI, 0.6-5.1) and 1.2 (95% CI, 0.3-4.7) for ASCUS/LSIL/high squamous intraepithelial lesions (HSIL). Respective ORs were 5.0 (95% CI, 1.7-14.6) and 2.8 (95% CI, 1.0-8.1) upon comparing women with HPV11 A2 variants to HPV11-negative women. All associations disappeared when adjusting for coinfections with high-risk HPV types.
Our data do not support an association between low-risk HPVs 6 and 11 genetic variability and cervical abnormalities.
Risk of cervical cytologic abnormalities is not affected by intratypic polymorphism in HPVs 6 and 11.
人乳头瘤病毒(HPV)6 型和 11 型主要与生殖器疣和复发性呼吸道乳头瘤病的发展有关。我们研究了巴西女性宫颈细胞学异常发展过程中这两种病毒类型的株内遗传变异性。
我们使用聚合酶链反应测序技术对 Ludwig-McGill 队列研究中宫颈拭子中的 HPV6 和/或 11 型病毒变体进行了特征描述。我们使用二项广义估计方程(GEE)模型和对数链接来估计 HPV6 和 11 型变体与细胞学异常之间的关联的比值比(OR)和 95%置信区间(CI)。
B1 和 B3 HPV6 和 A2 HPV11 变体是最常见的分离株。与 HPV6 阴性的女性相比,携带 HPV6 B1 或 B3 变体的女性中,非典型意义不明确细胞(ASCUS)/低度鳞状上皮内病变(LSIL)的 OR 分别为 6.3(95%CI,2.3-17.0)和 2.3(95%CI,0.6-9.7),ASCUS/LSIL/高度鳞状上皮内病变(HSIL)的 OR 分别为 1.7(95%CI,0.6-5.1)和 1.2(95%CI,0.3-4.7)。与 HPV11 阴性的女性相比,HPV11 A2 变体的女性的 OR 分别为 5.0(95%CI,1.7-14.6)和 2.8(95%CI,1.0-8.1)。当调整高危型 HPV 感染的合并感染时,所有关联均消失。
我们的数据不支持低危型 HPV6 和 11 遗传变异性与宫颈异常之间的关联。
HPV6 和 11 株内多态性不会影响宫颈细胞学异常的风险。